Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
5.735
Zitationen
24
Autoren
2019
Jahr
Abstract
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years. (Funded by Janssen Research and Development; CREDENCE ClinicalTrials.gov number, NCT02065791.).
Ähnliche Arbeiten
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
1985 · 31.117 Zit.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
1998 · 19.963 Zit.
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
1998 · 15.206 Zit.
International Diabetes Federation 2017
2018 · 13.548 Zit.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 · 11.700 Zit.
Autoren
- Vlado Perkovic
- Meg Jardine
- Bruce Neal
- Séverine Bompoint
- Hiddo J.L. Heerspink
- David M. Charytan
- Robert Edwards
- Rajiv Agarwal
- George L. Bakris
- Scott Bull
- Christopher P. Cannon
- George Capuano
- Pei-Ling Chu
- Dick de Zeeuw
- Tom Greene
- Adeera Levin
- Carol A. Pollock
- David C. Wheeler
- Yshai Yavin
- Hong Zhang
- Bernard Zinman
- Gary Meininger
- Barry M. Brenner
- Kenneth W. Mahaffey
Institutionen
- North Shore Hospital(NZ)
- Royal North Shore Hospital(AU)
- UNSW Sydney(AU)
- Concord Repatriation General Hospital(AU)
- The University of Sydney(AU)
- Imperial College London(GB)
- University of Groningen(NL)
- University Medical Center Groningen(NL)
- Baim Institute for Clinical Research(US)
- NYU Langone Health(US)
- Janssen (United States)(US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis(US)
- University of Chicago(US)
- University of Utah(US)
- University of British Columbia(CA)
- Peking University(CN)
- Peking University First Hospital(CN)
- University of Toronto(CA)
- Lunenfeld-Tanenbaum Research Institute(CA)
- Harvard University(US)
- Brigham and Women's Hospital(US)
- Stanford University(US)
- Center for Clinical Research (United States)(US)